IKARIA
Summary
Ikaria is a fully-integrated biotherapeutics company focused on developing and commercializing innovative therapeutics designed to meet the significant unmet medical needs of critically ill patients.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 1.54 B
Avg. Deal Size£ 1.54 B
All rights reserved. Copyright © 2025 Datasite
